SEC Comment Letter for Lifevantage Corp (LFVN) (CIK 0000849146) (LFVN) — Mar 31, 2020
Lifevantage Corp (LFVN) (CIK 0000849146)
Date: March 31, 2020 · CIK: 0000849146 · Accession: 0000000000-20-002782
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237376
Letter
March 31, 2020 Darren Jensen Chief Executive Officer LifeVantage Corporation 9785 S. Monroe Street, Suite 400 Sandy, UT 84070 Re:LifeVantage Corporation Registration Statement on Form S-3 Filed March 24, 2020 File No. 333-237376 Dear Mr. Jensen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kirt W. Shuldberg, Esq.
Show Raw Text
March 31, 2020
Darren Jensen
Chief Executive Officer
LifeVantage Corporation
9785 S. Monroe Street, Suite 400
Sandy, UT 84070
Re:LifeVantage Corporation
Registration Statement on Form S-3
Filed March 24, 2020
File No. 333-237376
Dear Mr. Jensen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Kirt W. Shuldberg, Esq.